From Aleafia 2 different sources. On August 12th Aleafia Reported Q2 ER and it is accounted for Under Cash and marketable securities. Aleafia's Q2 ended on June 30 2020. It is there. Now, Under Aphria I have no idea where it is itemized, in Q4 ER ending May 31. I cannot find the exact specifics of where it is listed. Perhaps someone could call Aphria or email Carl and find this out, so there is no doubt. Again it is listed in Aleafia's ER and is referenced in the canference call dated August 12 2020 for the q2 ending June 30.
Aphria personally cannot find it in the financial statements specifically.
https://www.globenewswire.com/news-release/2020/08/12/2077009/0/en/Aleafia-Health-Announces-Second-Quarter-2020-Results.html - Settlement of Claim
On June 25, 2020, the Company announced that Emblem and Aleafia Health entered into a settlement agreement (the “Settlement Agreement”) with Aphria to resolve their outstanding dispute in respect of the termination of the parties’ wholesale cannabis supply agreement. Under the terms of the Settlement Agreement, Emblem received total consideration of $29.1 million, comprised of $15.5 million cash payment, the issuance of common shares of Aphria with an aggregate market value of $10.0 million that are freely tradeable and transferable in Canada and a waiver of claimed receivables.
https://www.aleafiahealth.com/news-releases/3945/ h) Settlement of Claim
On June 25, 2020, the Company announced that Emblem and Aleafia Health entered into a settlement agreement (the “Settlement Agreement”) with Aphria to resolve their outstanding dispute in respect of the termination of the parties’ wholesale cannabis supply agreement. Under the terms of the Settlement Agreement, Emblem received total consideration of $29.1 million, comprised of $15.5 million cash payment, the issuance of common shares of Aphria with an aggregate market value of $10.0 million that are freely tradeable and transferable in Canada and a waiver of claimed receivables.